If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

Share Price is delayed by 15 minutes
Get Live Data
14.50    0.00 (0.00%)
Bid:
14.50
Ask:
14.95
Spread: 0.45 (3.103%)
Market Cap: £49.31m
BVC Live PriceLast checked at - London Stock Exchange

Intraday Batm Advanced Share Chart

New Carrier Ethernet Order

17 Nov 2025 07:00

RNS Number : 6945H
BATM Advanced Communications Ld
17 November 2025
 

LEI: 213800FLQUB9J289RU66

17 November 2025

 

BATM Advanced Communications Limited

("BATM" or "the Group") 

 

New Carrier Ethernet Order

BATM to power 10G edge upgrade for leading U.S. blue-chip broadband provider

 

BATM (LSE: BVC; TASE: BVC), a global provider of advanced network infrastructure, cybersecurity and diagnostic technologies, is pleased to announce that it has received an order for its 10G Carrier Ethernet and aggregation solutions from a leading internet services provider to homes and businesses across the U.S. (the "Customer"), which is owned by one of the world's largest technology conglomerates. The order, which is worth $670k, is to be delivered in the current year.

 

The order forms part of the Customer's programme to modernise its network by replacing its 1G platforms with 10G intelligent connectivity reaching outdoor and remote edge locations. This will involve upgrading hundreds of outdoor service cabinets to support multi-gigabit enterprise and residential access. These enclosures operate in challenging field environments - from sub-zero winters to desert heat - requiring compact, temperature-hardened, carrier-grade systems designed for high reliability and minimal maintenance.

 

The Group's solutions were chosen after tests by the Customer achieved a tenfold increase in edge bandwidth, simplified operations and reduced field interventions through built-in test heads and automated diagnostics. By deploying 10G intelligent connectivity with BATM's hardened platforms, the Customer is expanding the reach of carrier-grade performance to previously underserved edge environments and creating a new class of intelligent, cloud-connected edge sites capable of supporting hybrid-cloud traffic, low-latency content delivery and emerging AI-enabled applications. 

 

Moti Nagar, Chief Executive Officer of BATM, said: "We are pleased to have received this order from this household-name blue-chip customer as part of its network upgrade, which is a great validation of the strength of our network solutions. Pushing 10G to the far edge demands hardened reliability, automation and precision engineering - attributes our platforms were purpose-built to deliver. As the Customer continues to expand its service locations as well as execute on its mission to offer ever-faster internet speeds, we believe there is significant scope for further orders with this customer."

 

 

Enquiries

 

BATM

 

Moti Nagar, Chief Executive Officer

+972 9866 2525

Lior Miles, Chief Financial Officer

 

Shore Capital

 

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

+44 20 7408 4050 

 

 

Gracechurch Group

 

Harry Chathli, Claire Norbury

+44 20 4582 3500

KK Advisory

Kam Bansil, Steve Keeling

+44 20 7039 1901

 

 

Forward-looking statements  

This document contains forward-looking statements. Those statements reflect the current opinions, evaluations and estimations of the Group's management, and are based on the current data regarding the Group's business as is detailed in this document and in the Group's periodical, interim and immediate reports. The Group does not undertake any obligation or make any representation that actual results and events will be in line with those statements, and stresses that they may differ materially from those statements, due to changes in the Group's business, market, competition, demand for the Group's products or services, general economic factors or other factors that can influence the Group's business and results, due to the risk factors that are detailed in the Group's Annual Report, and due to information and factors that are currently unknown to the Group's management and that, if known, would affect the management's opinions, evaluations or estimations. The Group will report the actual results and events according to its legal, accounting and regulatory obligations, and does not undertake any other obligation to report them or their deviations from the forward-looking statements, or to update any of the forward-looking statements in this document or to report that it is not valid anymore.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFRLTLRLIE
Date   Source Headline
2nd Jul 20247:00 amRNSCommercial markets cybersecurity partnership
3rd Jun 20247:00 amRNSBlock Listing Interim Review
28th May 20247:00 amRNSBlock listing Interim Review
2nd May 20247:00 amRNSBATM selected for TB diagnostics programme
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.